Home › AstraZeneca plc (AZN) Price Target Cut to GBX 5,600 by Analysts at Deutsche Bank
 

Keywords :   


AstraZeneca plc (AZN) Price Target Cut to GBX 5,600 by Analysts at Deutsche Bank

2016-03-25 07:39:57| Biotech - Topix.net

The brokerage presently has a "buy" rating on the biopharmaceutical company's stock. Deutsche Bank's price objective suggests a potential upside of 43.33% from the stock's current price.

Tags: price bank cut target

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.07Tropical Storm Beryl Public Advisory Number 29A
06.07Summary for Tropical Storm Beryl (AT2/AL022024)
06.07Atlantic Tropical Weather Outlook
06.07Eastern North Pacific Tropical Weather Outlook
05.07Tropical Storm Beryl Potential Storm Surge Flooding Map
05.07Tropical Storm Beryl Probabilistic Storm Surge Graphics
05.07Tropical Storm Beryl Storm Surge Watch/Warning Map
05.07Tropical Storm Beryl Storm Surge Watch/Warning Map
More »